Dynasil Corporation Retains Carpe DM, Inc. for Investor Relations

Dynasil Corporation of America (OTCBB: DYSL), a rapidly growing manufacturer of specialized instruments, detectors and products with applications in homeland security/defense, cancer detection, medical and industrial, today announced that it has retained the services of Carpe DM, Inc. to handle investor relations.

“We are pleased to announce that Carpe DM will be working with us to expand our investor relations program as we continue to share the exciting news of our growth and opportunities. Carpe DM has extensive experience and had great success working with small, technologically advanced companies,” stated Craig T. Dunham, President and Chief Executive Officer of Dynasil Corporation of America.

Since 2001, Carpe DM has been involved with helping smallcap and microcap companies achieve recognition on Wall Street, in the media and their representative industries. Its current clients include CryoPort and Unilife Medical Solutions. Its former clients include Netsmart Technologies, which was acquired by a private equity firm, and Bioenvision, which was acquired by Genzyme.

Stuart Fine, CEO of Carpe DM, Inc. commented, “I very excited at the prospect of working with Dynasil. They have shown a remarkable capacity to deliver profitable growth for five consecutive years and have significant upside potential from its extensive technology portfolio. I look forward to helping Dynasil get the recognition it deserves.”

Dynasil recently announced that it is ranked number 207 on Technology Fast 500™, Deloitte LLP’s ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Additionally, it ranked number 10 on the 2009 Greater Philadelphia Fast 50, Deloitte’s ranking of 50 of the fastest growing technology, life sciences and cleantech companies in the Greater Philadelphia Region. Rankings in both are based on percentage of fiscal year revenue growth during the five year period from 2004—2008. During that period, Dynasil’s revenues grew 645%.

About Dynasil

Dynasil is a rapidly growing manufacturer of specialized instruments and products for a broad range of applications markets in the homeland security/defense, medical and general industrial sectors. In addition, the Company is engaged in a significant amount of contract research for the government and private industry. Dynasil and its subsidiaries have operations in New Jersey, New York and Massachusetts.

This news release may contain forward-looking statements usually containing the words “believe,” “expect,” “plan,” “target,” “intend” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act. Future results of operations projections, and expectations, which may relate to this release, involve certain risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the factors detailed in the Company’s Annual Report or Form 10-KSB and in the Company’s other Securities and Exchange Commission filings, continuation of existing market conditions and demand for our products.

Dynasil Corp of America (CE) (USOTC:DYSL)
Historical Stock Chart
From Jun 2024 to Jul 2024